新興感染症診断薬の世界市場レポート 2025年

新興感染症診断薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7％で352億1,000万米ドルに成長します。予測期間の成長は、人獣共通感染症の罹患率の上昇、規制の変更と支援の大幅な増加、万能ワクチンの開発、1つの健康アプローチへの注目の高まり、政府の支援と資金の増加に起因しています。予測期間における主な動向には、技術の進歩、次世代シーケンシング（NGS）、等温増幅技術、遠隔医療と遠隔診断、環境病原体モニタリングなどがあります。

人獣共通感染症の発生率の増加が、今後の新興感染症診断薬市場の成長を牽引すると予測されます。人獣共通感染症は、動物からヒトに感染する感染症であり、細菌、ウイルス、寄生虫、真菌などさまざまな病原体によって引き起こされます。人獣共通感染症の増加は、主に人間と野生動物の相互作用の激化、生息地の破壊、世界の旅行が原因であり、これらは種を超えた病原体の感染を促進します。新興感染症診断薬は、病原体の早期発見と正確な同定を可能にすることで、人獣共通感染症の管理に重要な役割を果たしています。この能力により、迅速な介入、効果的な治療、疾病発生の封じ込めが可能となり、動物から人への感染を減らすことができます。例えば、2024年2月、米国の政府機関であるウェストバージニア州が発表した「2022年人獣共通感染症報告書」によると、ライム病の報告件数は2021年の1,788件から2022年には2,449件に増加しました。したがって、人獣共通感染症の発生率の上昇が新興感染症診断薬市場の成長を促進しています。

この市場の主要企業は、競争力を高めるために分子診断プラットフォームなどの技術的進歩に注力しています。これらのプラットフォームは、核酸増幅技術を利用して病原体を高い感度と特異性で検出し、正確かつ早期の診断を可能にします。例えば、2022年5月、米国の医療機器メーカーであるベクトン・ディッキンソンアンドカンパニーは、完全自動化された高スループット診断プラットフォームであるBD COR MX/PXシステムを発表しました。このシステムは、サンプル処理から結果提供までの分子ワークフロー全体を自動化することで、検査室の効率を高める。その最初のアッセイであるBD CTGCTV2は、3つの一般的な非ウイルス性感染症（STI）を検出します。BD COR MX/PXシステムは、オンボードの試薬およびサンプル容量で最大1,700検体の処理が可能で、7時間以上の連続稼働を実現し、24時間で最大1,000の結果を提供することで、検査技師による手作業を大幅に削減します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界新興感染症診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の新興感染症診断薬市場：成長率分析
• 世界の新興感染症診断薬市場の実績：規模と成長, 2019-2024
• 世界の新興感染症診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界新興感染症診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の新興感染症診断薬市場感染タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイラル
• 細菌性
• 真菌
• その他の感染症
• 世界の新興感染症診断薬市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 呼吸器感染症
• 胃腸感染症
• 性感染症（STI）
• その他の病気の種類
• 世界の新興感染症診断薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）
• 等温核酸増幅技術（INAAT）
• 次世代シーケンシング（NGS）
• 免疫診断
• その他のテクノロジー
• 世界の新興感染症診断薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床検査
• ポイントオブケア検査
• 世界の新興感染症診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断研究所
• その他のエンドユーザー
• 世界の新興感染症診断薬市場、ウイルスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 呼吸器系ウイルス
• 肝炎ウイルス
• HIVとレトロウイルス
• アルボウイルス
• ヘルペスウイルス
• 胃腸ウイルス
• 新興ウイルス感染症
• 世界の新興感染症診断薬市場細菌の種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 結核（TB）
• メチシリン耐性黄色ブドウ球菌（MRSA）
• 大腸菌（大腸菌）感染症
• 連鎖球菌および肺炎球菌感染症
• クロストリジウム感染症
• ナイセリア
• 薬剤耐性菌の出現
• 世界の新興感染症診断薬市場真菌の種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• カンジダ症
• アスペルギルス症
• クリプトコッカス症
• ヒストプラズマ症
• コクシジオイデス症
• ニューモシスチス肺炎（PCP）
• 新興真菌感染症
• 世界の新興感染症診断薬市場その他の感染症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 寄生虫感染症
• 原虫感染症
• プリオン病
• 蠕虫感染症
• 非病原性または環境感染

第7章 地域別・国別分析

• 世界の新興感染症診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の新興感染症診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 新興感染症診断薬市場：競合情勢
• 新興感染症診断薬市場：企業プロファイル
  • Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson and Company
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Agilent Technologies Inc.
• Hologic Inc.
• Illumina Inc.
• bioMerieux SA
• QuidelOrtho Corporation
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• DiaSorin S.p.A.
• Randox Laboratories Ltd.
• Meridian Bioscience Inc.
• Sekisui Diagnostics LLC
• Copan Diagnostics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 新興感染症診断薬市場2029：新たな機会を提供する国
• 新興感染症診断薬市場2029：新たな機会を提供するセグメント
• 新興感染症診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Emerging infectious disease diagnostics involve advanced techniques and tools used to identify new or re-emerging infectious diseases caused by pathogens such as viruses, bacteria, or parasites. These diagnostics utilize cutting-edge technologies, including molecular testing, genomics, and rapid assays, to detect infections with speed and accuracy, thereby enhancing public health responses. They play a vital role in monitoring and controlling outbreaks and in the development of targeted treatments and vaccines.

The primary types of infections addressed by emerging infectious disease diagnostics include viral, bacterial, fungal, and others. Viral infections are diseases caused by viruses, which are minute pathogens that reproduce inside the host's cells. These include respiratory infections, gastrointestinal infections, and sexually transmitted infections (STIs). The technologies used for detection include polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), and immunodiagnostics, among others. Diagnostics can be applied in laboratory testing and point-of-care testing settings and are utilized by various end-users such as hospitals, clinics, diagnostic laboratories, and others.

The emerging infectious disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides emerging infectious disease diagnostics market statistics, including emerging infectious disease diagnostics industry global market size, regional shares, competitors with a emerging infectious disease diagnostics market share, detailed emerging infectious disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the emerging infectious disease diagnostics industry. This emerging infectious disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The emerging infectious disease diagnostics market size has grown strongly in recent years. It will grow from $22.13 billion in 2024 to $24.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing demand for point-of-care diagnostics, increasing prevalence of infectious diseases, increasing global population density, rising incidence of infectious diseases, and increasing healthcare expenditure.

The emerging infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $35.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rising incidence of zoonotic diseases, significant growth in regulatory changes and support, development of universal vaccines, increasing focus on one health approach, and rising government support and funding. Major trends in the forecast period include technological advancements, next-generation sequencing (NGS), isothermal amplification techniques, telemedicine and remote diagnostics, and environmental pathogen monitoring.

The increasing incidence of zoonotic diseases is projected to drive the growth of the emerging infectious disease diagnostics market in the future. Zoonotic diseases are infections that can be transmitted from animals to humans and are caused by various pathogens, including bacteria, viruses, parasites, or fungi. The rise in zoonotic diseases is primarily attributed to heightened human-wildlife interactions, habitat destruction, and global travel, which facilitate the transmission of pathogens across species. Emerging infectious disease diagnostics play a crucial role in managing zoonotic diseases by enabling early detection and accurate identification of pathogens. This capability allows for prompt intervention, effective treatment, and improved containment of disease outbreaks, thus reducing transmission from animals to humans. For example, in February 2024, the 2022 Zoonotic Disease Report published by the State of West Virginia, a US-based government agency, noted that the number of reported Lyme disease cases increased to 2,449 in 2022, up from 1,788 cases in 2021. Therefore, the rising incidence of zoonotic diseases is driving the growth of the emerging infectious disease diagnostics market.

Leading companies in this market are focusing on technological advancements, such as molecular diagnostic platforms, to gain a competitive edge. These platforms utilize nucleic acid amplification techniques to detect pathogens with high sensitivity and specificity, enabling accurate and early diagnosis. For instance, in May 2022, Becton Dickinson and Company, a US-based medical equipment manufacturer, introduced the BD COR MX/PX System, a fully automated, high-throughput diagnostic platform. This system enhances laboratory efficiency by automating the entire molecular workflow, from sample processing to result delivery. Its initial assay, the BD CTGCTV2, detects three common non-viral sexually transmitted infections (STIs). The BD COR MX/PX System can process up to 1,700 specimens with onboard reagent and sample capacity, providing over seven hours of continuous operation and delivering up to 1,000 results in 24 hours, significantly reducing manual handling by lab technicians.

In August 2022, Bio-Rad Laboratories Inc., a US-based life science research and clinical diagnostics company, acquired Curiosity Diagnostics for $170 million. This acquisition is notable for Bio-Rad as it enhances their portfolio by integrating Curiosity Diagnostics' PCR|ONE platform, a rapid diagnostics system designed specifically for molecular diagnostics. Curiosity Diagnostics, based in Poland, specializes in molecular diagnostic systems for managing infectious diseases.

Major companies operating in the emerging infectious disease diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.

North America was the largest region in the emerging infectious disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emerging infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the emerging infectious disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The emerging infectious disease diagnostics market consists of revenues earned by entities by providing services such as laboratory testing, diagnostic tool development, clinical interpretation of test results, surveillance and reporting, and the provision of telehealth consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The emerging infectious disease diagnostic market also includes sales of rapid test kits, polymerase chain reaction (PCR) machines, molecular diagnostic assays, sequencing platforms, point-of-care diagnostic devices, and biosensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emerging Infectious Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emerging infectious disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emerging infectious disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The emerging infectious disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Infection Type: Viral; Bacterial; Fungal; Other Infections
• 2) By Disease Type: Respiratory Infections; Gastrointestinal Infections; Sexually Transmitted Infections (STIs); Other Disease Types
• 3) By Technology: Polymerase Chain Reaction (PCR); Isothermal Nucleic Acid Amplification Technology (INAAT); Next-Generation Sequencing (NGS); Immunodiagnostics; Other Technologies
• 4) By Application: Laboratory Testing; Point-of-Care Testing
• 5) By End-User: Hospitals And Clinics; Diagnostics Laboratories; Other End-Users
• Subsegments:
• 1) By Viral: Respiratory Viruses; Hepatitis Viruses; HIV and Retroviruses; Arboviruses; Herpesviruses; Gastrointestinal Viruses; Emerging Viral Infections
• 2) By Bacterial: Tuberculosis (TB); Methicillin-Resistant Staphylococcus Aureus (MRSA); Escherichia Coli (E. coli) Infections; Streptococcus and Pneumococcus Infections; Clostridium Infections; Neisseria; Emerging Drug-Resistant Bacteria
• 3) By Fungal: Candidiasis; Aspergillosis; Cryptococcosis; Histoplasmosis; Coccidioidomycosis; Pneumocystis Pneumonia (PCP); Emerging Fungal Infections
• 4) By Other Infections: Parasitic Infections; Protozoan Infections; Prion Diseases; Helminthic Infections; Non-Pathogenic or Environmental Infections
• Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Emerging Infectious Disease Diagnostics Market Characteristics

3. Emerging Infectious Disease Diagnostics Market Trends And Strategies

4. Emerging Infectious Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Emerging Infectious Disease Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Emerging Infectious Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Emerging Infectious Disease Diagnostics Market Growth Rate Analysis
• 5.4. Global Emerging Infectious Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Emerging Infectious Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Emerging Infectious Disease Diagnostics Total Addressable Market (TAM)

6. Emerging Infectious Disease Diagnostics Market Segmentation

• 6.1. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral
• Bacterial
• Fungal
• Other Infections
• 6.2. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory Infections
• Gastrointestinal Infections
• Sexually Transmitted Infections (STIs)
• Other Disease Types
• 6.3. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Next-Generation Sequencing (NGS)
• Immunodiagnostics
• Other Technologies
• 6.4. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing
• Point-of-Care Testing
• 6.5. Global Emerging Infectious Disease Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostics Laboratories
• Other End-Users
• 6.6. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory Viruses
• Hepatitis Viruses
• HIV and Retroviruses
• Arboviruses
• Herpesviruses
• Gastrointestinal Viruses
• Emerging Viral Infections
• 6.7. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Bacterial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tuberculosis (TB)
• Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Escherichia Coli (E. coli) Infections
• Streptococcus and Pneumococcus Infections
• Clostridium Infections
• Neisseria
• Emerging Drug-Resistant Bacteria
• 6.8. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Fungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Candidiasis
• Aspergillosis
• Cryptococcosis
• Histoplasmosis
• Coccidioidomycosis
• Pneumocystis Pneumonia (PCP)
• Emerging Fungal Infections
• 6.9. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Other Infections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parasitic Infections
• Protozoan Infections
• Prion Diseases
• Helminthic Infections
• Non-Pathogenic or Environmental Infections

7. Emerging Infectious Disease Diagnostics Market Regional And Country Analysis

• 7.1. Global Emerging Infectious Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Emerging Infectious Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Emerging Infectious Disease Diagnostics Market

• 8.1. Asia-Pacific Emerging Infectious Disease Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Emerging Infectious Disease Diagnostics Market

• 9.1. China Emerging Infectious Disease Diagnostics Market Overview
• 9.2. China Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Emerging Infectious Disease Diagnostics Market

• 10.1. India Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Emerging Infectious Disease Diagnostics Market

• 11.1. Japan Emerging Infectious Disease Diagnostics Market Overview
• 11.2. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Emerging Infectious Disease Diagnostics Market

• 12.1. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Emerging Infectious Disease Diagnostics Market

• 13.1. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Emerging Infectious Disease Diagnostics Market

• 14.1. South Korea Emerging Infectious Disease Diagnostics Market Overview
• 14.2. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Emerging Infectious Disease Diagnostics Market

• 15.1. Western Europe Emerging Infectious Disease Diagnostics Market Overview
• 15.2. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Emerging Infectious Disease Diagnostics Market

• 16.1. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Emerging Infectious Disease Diagnostics Market

• 17.1. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Emerging Infectious Disease Diagnostics Market

• 18.1. France Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Emerging Infectious Disease Diagnostics Market

• 19.1. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Emerging Infectious Disease Diagnostics Market

• 20.1. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Emerging Infectious Disease Diagnostics Market

• 21.1. Eastern Europe Emerging Infectious Disease Diagnostics Market Overview
• 21.2. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Emerging Infectious Disease Diagnostics Market

• 22.1. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Emerging Infectious Disease Diagnostics Market

• 23.1. North America Emerging Infectious Disease Diagnostics Market Overview
• 23.2. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Emerging Infectious Disease Diagnostics Market

• 24.1. USA Emerging Infectious Disease Diagnostics Market Overview
• 24.2. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Emerging Infectious Disease Diagnostics Market

• 25.1. Canada Emerging Infectious Disease Diagnostics Market Overview
• 25.2. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Emerging Infectious Disease Diagnostics Market

• 26.1. South America Emerging Infectious Disease Diagnostics Market Overview
• 26.2. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Emerging Infectious Disease Diagnostics Market

• 27.1. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Emerging Infectious Disease Diagnostics Market

• 28.1. Middle East Emerging Infectious Disease Diagnostics Market Overview
• 28.2. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Emerging Infectious Disease Diagnostics Market

• 29.1. Africa Emerging Infectious Disease Diagnostics Market Overview
• 29.2. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Emerging Infectious Disease Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Emerging Infectious Disease Diagnostics Market Competitive Landscape
• 30.2. Emerging Infectious Disease Diagnostics Market Company Profiles
  • 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Emerging Infectious Disease Diagnostics Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Laboratory Corporation of America Holdings
• 31.3. Quest Diagnostics Incorporated
• 31.4. Agilent Technologies Inc.
• 31.5. Hologic Inc.
• 31.6. Illumina Inc.
• 31.7. bioMerieux SA
• 31.8. QuidelOrtho Corporation
• 31.9. Bio-Rad Laboratories, Inc.
• 31.10. Qiagen N.V.
• 31.11. DiaSorin S.p.A.
• 31.12. Randox Laboratories Ltd.
• 31.13. Meridian Bioscience Inc.
• 31.14. Sekisui Diagnostics LLC
• 31.15. Copan Diagnostics

32. Global Emerging Infectious Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Emerging Infectious Disease Diagnostics Market

34. Recent Developments In The Emerging Infectious Disease Diagnostics Market

35. Emerging Infectious Disease Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Emerging Infectious Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Emerging Infectious Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Emerging Infectious Disease Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33478_Emerging_Infectious_Disease_Diagnostics_GMR_2025